Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 77,826 shares at $47.93 ($3.8M) on 2020-01-21, disclosed to the SEC on 2020-01-23.
Seasonal sale ($3.8M) by Chief Financial Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.07 | 6,397 | $301K | 7.8% |
| 2 | $47.07 | 6,397 | $301K | 7.8% |
| 3 | $47.93 | 6,432 | $308K | 8.0% |
| 4 | $47.93 | 6,432 | $308K | 8.0% |
| 5 | $49.07 | 10,554 | $518K | 13.5% |
| 6 | $49.07 | 10,554 |
| $518K |
| 13.5% |
| 7 | $49.98 | 2,800 | $140K | 3.6% |
| 8 | $51.11 | 10,680 | $546K | 14.2% |
| 9 | $51.11 | 10,680 | $546K | 14.2% |
| 10 | $52.13 | 3,450 | $180K | 4.7% |
| 11 | $52.13 | 3,450 | $180K | 4.7% |
| Total | $49.42 avg | 77,826 | $3.8M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |